Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 620 participants.
Also called NCT01735227
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 620 participants
- Sponsor
- Yaling Han
- Registry
-
NCT01735227
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01735227. Randomized; single masking; primary purpose prevention. Start 2012-11 (registry gives no type); primary completion 2013-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)
- Condition
- Acute Coronary Syndromes
- Intervention (Drug)
- omeprazole
- Intervention (Drug)
- Pantoprazole
- Lead sponsor
- Yaling Han
Record details
- Record id
cardio:ct-nct01735227- Content hash
ecc93939a01635e13ac82863c2f69d95ba092f0c70b88f8816311580efdc092f